Exhausted CD8 + T Cell in HIV Infection Exhibits an Impaired Bioenergetic Metabolism Driven by Mitochondrial Dysfunction
- PMID: 41151591
- DOI: 10.1111/imm.70054
Exhausted CD8 + T Cell in HIV Infection Exhibits an Impaired Bioenergetic Metabolism Driven by Mitochondrial Dysfunction
Abstract
In people living with HIV (PLWH), persistent viral replication and antiretroviral therapy (ART)-associated toxicity contribute to T cell exhaustion, characterised by significant metabolic reprogramming that negatively impacts cellular function and longevity. Understanding the metabolic dysregulation in exhausted T cells could unveil novel therapeutic strategies to rejuvenate immune responses in PLWH. This study investigated the prevalence and metabolic gene expression profiles of exhausted CD8+ T cells across three PLWH cohorts: viremic treatment-naïve (TN), viremic treatment-failure (TF) and aviremic treatment-responders (TR). Our analysis revealed that the proportion of exhausted CD8+ T cells (PD1+CD107a-) was markedly higher in viremic TN (5.1%) and TF (4.2%) groups compared to the aviremic TR cohort (2.2%, p < 0.05). Similarly, the percentage of terminally differentiated TEMRA cells (CCR7-CD45RA+) was elevated in TN (38.0%) and TF (44.7%) compared with TR (21.5%, p < 0.05), indicating a higher prevalence of late-stage differentiation and exhaustion in viremic individuals. NanoString analysis revealed a broad downregulation of metabolic genes in exhausted CD8+ T cells from viremic individuals, suggesting a shift toward a metabolically quiescent state akin to naïve T cells. Seahorse analysis revealed impaired mitochondrial respiration in CD8+ T cells from viremic PLWH, characterised by reductions in both ATP-linked respiration and proton leak. Furthermore, we reported that combined treatment with MitoTEMPO and N-acetyl-l-cysteine (NAC) improved mitochondrial function but failed to restore the effector capacity of CD8+ T cells. In summary, this study highlights the defective metabolic programming of exhausted CD8+ T cells in viremic PLWH, underscoring potential metabolic targets for therapeutic intervention.
Keywords: CD8+ T cell; HIV; T cell exhaustion; metabolic pathways; mitochondria; people living with HIV (PLWH).
© 2025 John Wiley & Sons Ltd.
References
-
- Global HIV Statistics, “Global HIV Statistics—Fact Sheet 2023,” 2023, https://www.unaids.org/en/resources/fact‐sheet.
-
- V. D. Lima, R. Harrigan, D. R. Bangsberg, et al., “The Combined Effect of Modern Highly Active Antiretroviral Therapy Regimens and Adherence on Mortality Over Time,” JAIDS Journal of Acquired Immune Deficiency Syndromes 50 (2009): 529–536.
-
- D. A. Kulpa and N. Chomont, “HIV Persistence in the Setting of Antiretroviral Therapy: When, Where and How Does HIV Hide?,” Journal of Virus Eradication 1 (2015): 59–66.
-
- W. Popik, T. M. Alce, and W.‐C. Au, “Human Immunodeficiency Virus Type 1 Uses Lipid Raft‐Colocalized CD4 and Chemokine Receptors for Productive Entry Into CD4+ T Cells,” Journal of Virology 76 (2002): 4709–4722.
-
- J. A. Warren, G. Clutton, and N. Goonetilleke, “Harnessing CD8+ T Cells Under HIV Antiretroviral Therapy,” Frontiers in Immunology 10 (2019): 291.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
